![]() |
Name |
Trimethylsilyl 2,6-bis[(trimethylsilyl)oxy]benzoate
|
Molecular Formula | C16H30O4Si3 | |
IUPAC Name* |
trimethylsilyl 2,6-bis(trimethylsilyloxy)benzoate
|
|
SMILES |
C[Si](C)(C)OC1=C(C(=CC=C1)O[Si](C)(C)C)C(=O)O[Si](C)(C)C
|
|
InChI |
InChI=1S/C16H30O4Si3/c1-21(2,3)18-13-11-10-12-14(19-22(4,5)6)15(13)16(17)20-23(7,8)9/h10-12H,1-9H3
|
|
InChIKey |
APVNJYLNHAHELF-UHFFFAOYSA-N
|
|
Synonyms |
2,6-Bis(trimethylsilyloxy)benzoic acid trimethylsilyl ester; Benzoic acid, 2,6-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester; 3782-85-2; Trimethylsilyl 2,6-bis[(trimethylsilyl)oxy]benzoate; DTXSID301346412; Benzoic acid, 2,6-dihydroxy, tri-TMS; 2,6-Dihydroxybenzoic acid, 3TMS derivative; Q63391901; Trimethylsilyl 2,6-bis[(trimethylsilyl)oxy]benzoate #; 2,6-Dihydroxybenzoic acid, bis(trimethylsilyl) ether, trimethylsilyl ester
|
|
CAS | 3782-85-2 | |
PubChem CID | 520869 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 370.66 | ALogp: | 5.1 |
HBD: | 0 | HBA: | 4 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 44.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 23 | QED Weighted: | 0.627 |
Caco-2 Permeability: | -5.204 | MDCK Permeability: | 0.00001840 |
Pgp-inhibitor: | 0.1 | Pgp-substrate: | 0.021 |
Human Intestinal Absorption (HIA): | 0.984 | 20% Bioavailability (F20%): | 0.819 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0.001 | Plasma Protein Binding (PPB): | 96.40% |
Volume Distribution (VD): | 4.083 | Fu: | 13.75% |
CYP1A2-inhibitor: | 0.955 | CYP1A2-substrate: | 0.986 |
CYP2C19-inhibitor: | 0.099 | CYP2C19-substrate: | 0.839 |
CYP2C9-inhibitor: | 0.597 | CYP2C9-substrate: | 0.906 |
CYP2D6-inhibitor: | 0.038 | CYP2D6-substrate: | 0.527 |
CYP3A4-inhibitor: | 0.049 | CYP3A4-substrate: | 0.186 |
Clearance (CL): | 2.568 | Half-life (T1/2): | 0.314 |
hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.001 |
Drug-inuced Liver Injury (DILI): | 0.015 | AMES Toxicity: | 0.035 |
Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.066 |
Skin Sensitization: | 0.931 | Carcinogencity: | 0.024 |
Eye Corrosion: | 0.944 | Eye Irritation: | 0.989 |
Respiratory Toxicity: | 0.361 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001123 | ![]() |
0.686 | D06TQZ | ![]() |
0.229 | ||
ENC001122 | ![]() |
0.487 | D0FN7J | ![]() |
0.218 | ||
ENC001182 | ![]() |
0.476 | D08USJ | ![]() |
0.217 | ||
ENC001404 | ![]() |
0.421 | D01JFT | ![]() |
0.216 | ||
ENC001272 | ![]() |
0.349 | D0WY5Q | ![]() |
0.202 | ||
ENC001399 | ![]() |
0.341 | D0U9QU | ![]() |
0.202 | ||
ENC000530 | ![]() |
0.325 | D01PJR | ![]() |
0.200 | ||
ENC001270 | ![]() |
0.316 | D0X4RN | ![]() |
0.193 | ||
ENC001385 | ![]() |
0.299 | D05SJW | ![]() |
0.193 | ||
ENC001175 | ![]() |
0.271 | D06REO | ![]() |
0.192 |